Identification | More | [Name]
1,3-PROPANEDISULFONIC ACID DISODIUM SALT | [CAS]
36589-58-9 | [Synonyms]
1,3-PROPANEDISULFONIC ACID DISODIUM SALT DISODIUM 1,3-PROPANEDISULFONATE DISODIUM 1,3-PROPANEDISULPHONATE DISODIUM PROPANE-1,3-DISULFONATE 1,3-propanedisulfonic acid disodium ,3-PROPANEDISULFONIC ACID DISODIUM SALT 1,3-Propanedisulfonic acid disodium salt, 99%(dry wt.), water <5% | [Molecular Formula]
C3H6Na2O6S2 | [MDL Number]
MFCD00191483 | [Molecular Weight]
248.19 | [MOL File]
36589-58-9.mol |
Chemical Properties | Back Directory | [Appearance]
White coarse powder | [Melting point ]
>300°C | [storage temp. ]
Inert atmosphere,Room Temperature | [form ]
powder to crystal | [color ]
White to Almost white | [Water Solubility ]
Partially soluble in cold water, hot water. | [Sensitive ]
Hygroscopic | [BRN ]
3767479 | [CAS DataBase Reference]
36589-58-9(CAS DataBase Reference) |
Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36:Wear suitable protective clothing . | [WGK Germany ]
3
| [HS Code ]
29041000 |
Hazard Information | Back Directory | [Chemical Properties]
White coarse powder | [Uses]
Reactant involved in synthesis of:
- Cadmium(II) bipyridine complex metal-organic frameworks with alkanedisulfonates
- Alkylenedisulfonate inorganic-organic hybrid materials
Glycosaminoglycan mimetic involved in pharmacological studies for the treatment of amyloid A amyloidosis | [Uses]
It is used as a reactant involved in synthesis of cadmium(II) bipyridine complex metal-organic frameworks with alkanedisulfonates, alkylenedisulfonate inorganic-organic hybrid materials and glycosaminoglycan mimetic involved in pharmacological studies for the treatment of amyloid A amyloidosis. | [Uses]
keratolytic | [Synthesis]
Step 3: To a methanolic (15 mL) suspension of the disulfone compound (0.62 g, 2.23 mmol) obtained in Step 2, a methanolic solution of 0.5 M sodium methanol (8.9 mL, 4.58 mmol) was slowly added. The reaction mixture was stirred at room temperature for 24 hours. After completion of the reaction, the homogeneous reaction solution was concentrated under reduced pressure to give a solid. The solid was suspended in ethanol (20 mL) and stirred at room temperature for 1 hour. Subsequently, the solid was separated by filtration and the filter cake was washed sequentially with ethanol (2 x 10 mL) and ether (2 x 10 mL). The resulting solid was dissolved in water (2 mL) and purified by passing through a C8 reversed-phase silica gel pad, using water as eluent. The eluate containing sodium 1,3-propanedisulfonate (P1, disodium salt) was collected and lyophilized to give sodium 1,3-propanedisulfonate (0.41 g, 85% yield) in white solid form. The structure of the product was confirmed by 1H NMR (D2O, 500 MHz): δ 1.84 (quintuple peak, J = 8.0 Hz, 2H), 2.44 (triple peak, J = 8.0 Hz, 4H). | [storage]
Store at -20°C | [References]
[1] Patent: WO2011/17800, 2011, A1. Location in patent: Page/Page column 100 |
|
Company Name: |
Alcatraz Chemicals
|
Tel: |
+91-2652340422 +91-7433813484 |
Website: |
www.alcatrazchemicals.com |
|